Drug Channels

JUNE 21, 2022

National Association of Specialty Pharmacy (NASP) 2022 Annual Meeting & Expo. September 19-22, 2022 | Gaylord Palms Resort & Convention Center | Orlando, FL. www.naspnet.org/annualmeeting. The National Association of Specialty Pharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22. NASP will celebrate their 10th Anniversary and welcome attendees to a new conference venue – the gorgeous Gaylord Palms Resort & Convention Center, located in Orlando, Florida.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Nurses Hospitals 98

Drug Patent Watch

JUNE 18, 2022

Annual Drug Patent Expirations for GLEEVEC Gleevec is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There is one patent protecting…. The post New patent expiration for Novartis drug GLEEVEC appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

The Open Targets Blog

JUNE 24, 2022

The latest release of the Platform — 22.06 — is now available at platform.opentargets.org. Key points We have included five additional studies in our Gene Burden widget, incorporating evidence from a number of different therapeutic areas The term “ medical procedure ” has been added to our ontology Users can now visualise subcellular locations of targets Key stats Metric Count Targets 61,524 Diseases 23,074 Drugs 12,854 Evidence strings 14,455,104 Associations 7,247,8

Disease 52

Disease Drugs 52

EG Life Sciences

JUNE 22, 2022

The pharmaceutical industry is one of the most highly regulated industries, and for good reason. These organizations are tasked with protecting the rights and well-being of subjects, along with the integrity of data and analysis. As a result, audits are a crucial part of our business.

Regulations 52

Regulations Pharmaceuticals Compliance 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Channels

JUNE 24, 2022

Today’s guest post comes from Logan Melchione, Senior Director of Account Management at Paysign. Logan describes how some patient affordability vendors capture funds that were intended for patients. She then provides manufacturers with ideas to better manage and oversee copay, bridge, and voucher programs. To learn more, register for Paysign’s July 13 webinar: Affording Patient Affordability Programs: The Truth About Voucher and Bridge Pricing.

Drugs 98

Drugs 98

Drug Patent Watch

JUNE 24, 2022

Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Mylan Speciality drug ELESTRIN appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

The Pharma Data

JUNE 19, 2022

Most skin cancer drugs that activate the immune system work by triggering immune cells, called T cells, to attack tumors, but when T cells are activated for too long, they can wear out and cease to function. A new study led by Penn State College of Medicine scientists finds that another type of immune cell – natural killer cells – can be harnessed to pick up the slack when T cells no longer work and may also reinvigorate T cells to attack melanoma tumors.

Drugs 52

Drugs Immune Response Research Treatment 52

Drug Channels

JUNE 22, 2022

Recently, I explored the complex web of relationships and conflicts that support today’s discount card economics. See The GoodRx-Kroger Blowup: Spread Pricing, Pharmacy Margins, and the Future of Discount Cards. In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business.

Pharmacy 97

Pharmacy Drugs 97

Drug Patent Watch

JUNE 24, 2022

Annual Drug Patent Expirations for GELNIQUE+3%25 Gelnique 3% is a drug marketed by Allergan and is included in one NDA. There is one patent protecting this drug. Drug patent litigation…. The post New patent expiration for Allergan drug GELNIQUE 3% appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Crown Bioscience

JUNE 22, 2022

Do you ever wonder how tumor organoids and ex vivo microtumors (i.e., patient tumor material) are being used in immuno-oncology (I/O)?

52

52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Pharma Manufacturing

JUNE 24, 2022

Pharma can do better than 50% compliance

Compliance 73

Compliance 73

The Open Targets Blog

JUNE 21, 2022

My name is Carlos Cruz. I'm a software engineer focused on front end. As part of the Open Targets team, I work on maintaining and developing the Open Targets web applications. At Open Targets, we maintain two UI applications: the Open Targets Platform and Open Targets Genetics. Both are JavaScript applications that use React , GraphQL , and MUI , among other libraries.

Packaging 52

Packaging Engineering 52

Drug Patent Watch

JUNE 24, 2022

Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug. This drug has…. The post New patent expiration for Oncopeptides Ab drug PEPAXTO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Creative Biolabs

JUNE 20, 2022

In a new study, researchers from Emory University revealed that cancer-causing mutations result in widespread distortions in protein-protein interaction networks in cells. The findings were recently published online in the journal Cell. “A mutation that causes cancer is an altered protein-protein interaction network. The mutation may form a new epitope—a new interaction surface,” said Dr.

Therapies 52

Therapies Regulations FDA Research 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Pharma Manufacturing

JUNE 20, 2022

Advanced automation can speed the validation process, helping pharma projects come online faster

40

40

Nvidia Developer: Drug Discovery

JUNE 24, 2022

The field of drug discovery is at a fascinating inflection point. The physics of the problem are understood and calculable, yet quantum mechanical calculations. The field of drug discovery is at a fascinating inflection point. The physics of the problem are understood and calculable, yet quantum mechanical calculations are far too expensive and time consuming.

Drugs 52

Drugs Computational Chemistry FDA Approval Research 52

Drug Patent Watch

JUNE 24, 2022

Annual Drug Patent Expirations for APTIOM Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…. The post New patent for Sunovion Pharms drug APTIOM appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug & Device Law

JUNE 24, 2022

Summary judgment was affirmed in Vesoulis v. ReShape LifeSciences, Inc. , 2022 WL 989465 (5th Cir. April 1, 2022), although the recent troubling trend towards non-precedential defense wins but precedential defense losses continues. Vesoulis was a one-off suit under Louisiana law against the manufacturer of a pre-market (“PMA”)-approved medical device and the implanting – or, more properly, explanting – surgeon.

Production 52

Production Regulations Marketing Drugs 52

Pharma Manufacturing

JUNE 21, 2022

Did short-term solutions for COVID-19 stifle long-term mRNA success?

40

40

Drug Patent Watch

JUNE 24, 2022

Annual Drug Patent Expirations for TIBSOVO Tibsovo is a drug marketed by Servier and is included in one NDA. There are eight patents protecting this drug. This drug has one…. The post New patent for Servier drug TIBSOVO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

JUNE 24, 2022

Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…. The post New patent for Otsuka Pharm drug ABILIFY MAINTENA KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

JUNE 23, 2022

Annual Drug Patent Expirations for GATTEX+KIT Gattex Kit is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are…. The post New patent for Takeda Pharms drug GATTEX KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

JUNE 22, 2022

Annual Drug Patent Expirations for ZEMBRACE+SYMTOUCH Zembrace Symtouch is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There is…. The post New patent for Upsher Smith drug ZEMBRACE SYMTOUCH appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

JUNE 21, 2022

Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eighteen…. The post New patent for Gilead Sciences drug VOSEVI appeared first on DrugPatentWatch - Make Better Decisions.

Science 52

Science Drugs Marketing 52

Drug Patent Watch

JUNE 21, 2022

Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are four patents protecting…. The post New patent for Chiesi drug FERRIPROX appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

JUNE 21, 2022

Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug. This drug has…. The post New patent for Oncopeptides Ab drug PEPAXTO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

JUNE 21, 2022

Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are six patents protecting this drug. This drug has…. The post New patent for Deciphera Pharms drug QINLOCK appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

JUNE 23, 2022

This chart shows the pharmaceutical companies with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovakia? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceuticals Drugs 98

Drug Patent Watch

JUNE 24, 2022

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Italy? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals 52

Drug Patent Watch

JUNE 22, 2022

This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Luxembourg? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Drugs 52

Drug Patent Watch

JUNE 19, 2022

This chart shows the drugs with the most patents in Peru. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Peru? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 52

Pharmaceuticals Drugs 52

Drug Patent Watch

JUNE 18, 2022

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals 52

Drug Patent Watch

JUNE 21, 2022

This chart shows the pharmaceutical companies with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent…. The post Which pharmaceutical companies have the most drug patents in European Patent Office? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceuticals Drugs 40

Drug Patent Watch

JUNE 20, 2022

This chart shows the drugs with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Israel? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 52

Pharmaceuticals Drugs 52